Home » Topics » BioWorld Science

BioWorld Science
RSS

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

April 27, 2022

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

April 27, 2022

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

April 27, 2022

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

April 27, 2022

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

April 27, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...